IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
This article was originally published in SRA
Executive Summary
The EU's Innovative Medicines Initiative (IMI) is to launch a new collaborative programme in the next few months aimed at boosting the discovery and development of novel antimicrobial medicines, as pressure grow for more action to tackle the problem of bacterial resistance1.